Tag: NeuroScientific Biopharmaceuticals
NeuroScientific begins cell therapy manufacturing transfer to Q-Gen
NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) has commenced the transfer of its patented cell manufacturing process to Q-Gen Cell Therapeutics, a move the company says is a key step in advancing its clinical development and commercialisation plans.
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
